Romankiewicz J A, McManus J, Gotz V P, Carlin H S
Am J Hosp Pharm. 1979 Nov;36(11):1541-5.
A survey of selected drug labelers was conducted to generate a list of drug products that should not be refrigerated. Letters asking for information on products adversely affected by refrigeration were mailed to 109 drug product labelers. A second letter was sent to nonresponders and to labelers providing incomplete information. Responses were received from 97 labelers, 43 of whom stated that none of their products would be harmed by refrigeration. Eleven labelers were unable to provide conclusive data or a list of specific drug products that refrigeration would harm. Lists of drug products not to be refrigerated were provided by 43 labelers, some including explanations of the adverse effects of refrigeration. Pharmacists may find the survey's data useful in their patient education activities.
对选定的药品标签商进行了一项调查，以生成一份不应冷藏的药品清单。向109家药品标签商邮寄了询问受冷藏影响的产品信息的信件。第二封信发送给了未回复者以及提供信息不完整的标签商。收到了97家标签商的回复，其中43家表示其产品均不会因冷藏而受损。11家标签商无法提供确凿数据或冷藏会造成损害的具体药品清单。43家标签商提供了不应冷藏的药品清单，有些还包括冷藏不良反应的解释。药剂师可能会发现该调查数据对他们的患者教育活动有用。
